T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$2.6B |
| 2 |
BNY
Bank of New York Mellon
BNY
|
+$1.1B |
| 3 |
Elevance Health
ELV
|
+$903M |
| 4 |
DD
Du Pont De Nemours E I
DD
|
+$873M |
| 5 |
Medtronic
MDT
|
+$868M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan Inc
AGN
|
+$3.89B |
| 2 |
COV
COVIDIEN PLC COM SHS NEW (IRELAND)
COV
|
+$1.06B |
| 3 |
CFN
CAREFUSION CORPORATION
CFN
|
+$946M |
| 4 |
Aptiv
APTV
|
+$886M |
| 5 |
KSU
Kansas City Southern
KSU
|
+$662M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 21.05% |
| 2 | Consumer Discretionary | 13.82% |
| 3 | Financials | 13.14% |
| 4 | Industrials | 11.9% |
| 5 | Technology | 9.68% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
426
Fastenal
FAST
$58.9B
| $210M | 0.04% |
20,320,852
-12,690,052
| -38% | -$137M |
|
427
RBC Bearings
RBC
$17.5B
| $209M | 0.04% |
2,729,310
-34,405
| -1% | -$2.16M |
|
|
SCHW
428
Charles Schwab
SCHW
$190B
| $209M | 0.04% |
6,861,942
+61,040
| +0.9% | +$1.77M |
|
|
TXNM
429
TXNM Energy Inc
TXNM
$5.91B
| $209M | 0.04% |
7,141,352
+192,150
| +3% | +$5.59M |
|
|
SEM
430
DELISTED
Select Medical
SEM
| $208M | 0.04% |
26,091,709
+2,964,730
| +13% | +$22.2M |
|
431
Lam Research
LRCX
$422B
| $208M | 0.04% |
29,658,850
+4,892,390
| +20% | +$38.7M |
|
432
Trane Technologies
TT
$105B
| $208M | 0.04% |
3,059,268
+794,285
| +35% | +$52.5M |
|
433
Texas Capital Bancshares
TCBI
$4.38B
| $207M | 0.04% |
4,259,038
-216,840
| -5% | -$10.2M |
|
|
KKD
434
DELISTED
KRISPY KREME DOUGHNUTS INC
KKD
| $206M | 0.04% |
10,315,204
+638,340
| +7% | +$13M |
|
435
Home BancShares
HOMB
$6.27B
| $205M | 0.04% |
12,115,334
+424,368
| +4% | +$6.72M |
|
436
Broadcom
AVGO
$1.99T
| $205M | 0.04% |
16,122,700
-517,700
| -3% | -$5.94M |
|
|
JOY
437
DELISTED
Joy Global Inc
JOY
| $205M | 0.04% |
5,221,379
+10,600
| +0.2% | +$449K |
|
438
Acadia Healthcare
ACHC
$2.82B
| $205M | 0.04% |
2,856,983
+7,740
| +0.3% | +$496K |
|
|
TSRO
439
DELISTED
TESARO, Inc.
TSRO
| $203M | 0.04% |
3,538,524
+1,007,985
| +40% | +$47.5M |
|
440
Mettler-Toledo International
MTD
$28.7B
| $200M | 0.04% |
610,007
+3,623
| +0.6% | +$1.12M |
|
|
RTN
441
DELISTED
Raytheon Company
RTN
| $198M | 0.04% |
1,813,405
+8,302
| +0.5% | +$893K |
|
442
Acadia Pharmaceuticals
ACAD
$4.89B
| $197M | 0.04% |
6,057,423
-183,375
| -3% | -$6.3M |
|
|
BHI
443
DELISTED
Baker Hughes
BHI
| $196M | 0.04% |
3,086,289
+233,370
| +8% | +$14.1M |
|
444
Mercado Libre
MELI
$92.7B
| $192M | 0.04% |
1,563,683
+180,791
| +13% | +$22.8M |
|
|
MKTO
445
DELISTED
MARKETO INC COM STK (DE)
MKTO
| $190M | 0.04% |
7,426,547
+523,642
| +8% | +$15.6M |
|
|
TRCO
446
DELISTED
TRIBUNE MEDIA COMPANY CLASS A
TRCO
| $190M | 0.04% |
3,121,102
+2,088,002
| +202% | +$128M |
|
|
PRA
447
DELISTED
ProAssurance
PRA
| $188M | 0.04% |
4,088,008
-215,626
| -5% | -$9.81M |
|
|
BERY
448
DELISTED
Berry Global Group, Inc.
BERY
| $187M | 0.04% |
5,625,276
-198,823
| -3% | -$6.25M |
|
|
KATE
449
DELISTED
Kate Spade & Company
KATE
| $186M | 0.04% |
5,561,980
-116,089
| -2% | -$3.68M |
|
450
Edgewell Personal Care
EPC
$1.31B
| $185M | 0.04% |
1,809,570
-167,751
| -8% | -$16.6M |
|
Similar funds
T. Rowe Price Associates's Q1 2015 Portfolio in Review
As of Q1 2015, T. Rowe Price Associates held 2,630 positions worth $484B, up 2.8% from $471B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
T. Rowe Price Associates's Q1 2015 filing shows 93 new, 1,078 increased, 887 reduced and 93 closed positions. Its largest new stake was ACTAVIS PLC Pfd Conv Ser A (Irl): 516,600 shares worth $532M. The largest sale was Allergan Inc, an estimated $3.89B.
By sector, the portfolio is most concentrated in Healthcare at 21% of assets, up from 20% a quarter earlier, followed by Consumer Discretionary and Financials.
- T. Rowe Price Associates's largest Q1 2015 buy was ACTAVIS PLC Pfd Conv Ser A (Irl): 516,600 shares worth $532M.
- T. Rowe Price Associates added most to Allergan plc in Q1 2015, an estimated $2.6B increase.
- T. Rowe Price Associates's biggest Q1 2015 reduction was Aptiv, cutting an estimated $886M.
- T. Rowe Price Associates fully exited Allergan Inc in Q1 2015, selling an estimated $3.89B.
- T. Rowe Price Associates's ten largest holdings make up 13% of its $484B portfolio in Q1 2015.
- T. Rowe Price Associates opened 93 new positions and closed 93 in Q1 2015.
- T. Rowe Price Associates's portfolio value rose 2.8% quarter-over-quarter to $484B.
Based on T. Rowe Price Associates's 13F filing for Q1 2015, filed 15 May 2015.